LAVA Therapeutics Statistics

Total Valuation

LVTX has a market cap or net worth of $34.72 million. The enterprise value is -$31.52 million.

Market Cap	34.72M
Enterprise Value	-31.52M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

LVTX has 26.31 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	26.31M
Shares Outstanding	26.31M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	8.54%
Float	10.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.11
Forward PS	n/a
PB Ratio	1.35
P/TBV Ratio	1.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.73, with a Debt / Equity ratio of 0.01.

Current Ratio	6.73
Quick Ratio	6.42
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-60.98

Financial Efficiency

Return on equity (ROE) is -73.21% and return on invested capital (ROIC) is -47.27%.

Return on Equity (ROE)	-73.21%
Return on Assets (ROA)	-23.02%
Return on Invested Capital (ROIC)	-47.27%
Return on Capital Employed (ROCE)	-51.56%
Revenue Per Employee	$146,765
Profits Per Employee	-$823,088
Employee Count	34
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, LVTX has paid $786,000 in taxes.

Income Tax	786,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.45, so LVTX's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-50.00%
50-Day Moving Average	1.26
200-Day Moving Average	1.40
Relative Strength Index (RSI)	56.92
Average Volume (20 Days)	33,198

Short Selling Information

The latest short interest is 88,992, so 0.34% of the outstanding shares have been sold short.

Short Interest	88,992
Short Previous Month	106,138
Short % of Shares Out	0.34%
Short % of Float	0.87%
Short Ratio (days to cover)	1.88

Income Statement

In the last 12 months, LVTX had revenue of $4.99 million and -$27.99 million in losses. Loss per share was -$1.04.

Revenue	4.99M
Gross Profit	-19.56M
Operating Income	-31.35M
Pretax Income	-28.31M
Net Income	-27.99M
EBITDA	-30.92M
EBIT	-31.35M
Loss Per Share	-$1.04

Full Income Statement

Balance Sheet

The company has $66.56 million in cash and $312,000 in debt, giving a net cash position of $66.25 million or $2.52 per share.

Cash & Cash Equivalents	66.56M
Total Debt	312,000
Net Cash	66.25M
Net Cash Per Share	$2.52
Equity (Book Value)	25.78M
Book Value Per Share	0.98
Working Capital	59.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-30.35M
Capital Expenditures	n/a
Free Cash Flow	-30.35M
FCF Per Share	-$1.15

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-628.16%
Pretax Margin	-545.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-80.60%
FCF Yield	-87.39%

Analyst Forecast

The average price target for LVTX is $1.75, which is 32.58% higher than the current price. The consensus rating is "Hold".

Price Target	$1.75
Price Target Difference	32.58%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-15.33%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LVTX has an Altman Z-Score of -3.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.27
Piotroski F-Score	n/a